Related Experiment Videos
Medulloblastoma. Treatment results
Acta Radiologica: Oncology, Radiation, Physics, Biology
|January 1, 1978
Summary
This study on medulloblastoma treatment found 3-year and 5-year survival rates of 36% and 33% respectively, with no significant difference between genders.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Radiation oncology
Background:
- Medulloblastoma is a common malignant brain tumor in children.
- Treatment typically involves surgery and radiation therapy.
- Long-term survival rates and prognostic factors require further investigation.
Purpose of the Study:
- To evaluate the survival outcomes of medulloblastoma patients treated with surgery and whole central nervous system (CNS) irradiation.
- To assess potential differences in prognosis based on age group and gender.
Main Methods:
- Retrospective analysis of 44 patients diagnosed with medulloblastoma.
- Treatment protocol included primary surgical resection followed by whole CNS irradiation.
- Survival rates were calculated at 3 and 5 years post-treatment.
Main Results:
- The overall 3-year survival rate was 36%, and the 5-year survival rate was 33%.
- For children exclusively, the 3-year survival rate was 37%, and the 5-year survival rate was 33%.
- No statistically significant difference in prognosis was observed between male and female patients.
Conclusions:
- Primary surgery followed by whole CNS irradiation yields moderate survival rates for medulloblastoma.
- Age (pediatric vs. adult) and gender do not appear to be significant prognostic indicators in this cohort.
- Further research is warranted to explore novel therapeutic strategies to improve medulloblastoma outcomes.